Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions of end-of-life care quality among bereaved closest contacts of community-dwelling older Australians: a cross-sectional survey of the ASPREE cohort.

Research square·2026
Same author

Metabolomic signatures prior to in-hospital cardiac arrest: insights into potential therapeutic targets.

Scientific reports·2026
Same author

Percutaneous dilatational tracheostomy in critical illness: A practice survey of intensivists in Australia and New Zealand.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same author

Prevalence and characteristics of intensive care unit follow-up services in Australia and New Zealand: A binational survey.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Socioeconomic disadvantage and sepsis survival in Australian intensive care units: A retrospective cohort study.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Community-Based Physician Attitudes Related to the Diagnosis and Treatment of Early Alzheimer's Disease in the United States.

American journal of Alzheimer's disease and other dementias·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Cardiovascular-kidney-metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Changes in DNA methylation-based aging predicts brain damage and dementia and reflects life-course cardiovascular risk.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Elimination of tau tangles and soluble aggregates with the small molecule ACI-16664 prevents neurodegeneration in vivo.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Daryl Jones1, Jo Vandercappellen1, Leah Zullig2

  • 1Eisai Inc., Nutley, NJ, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

High-accuracy blood-based biomarkers (BBMs) show promise for Alzheimer's disease (AD) diagnosis. This study assesses their feasibility and identifies barriers to implementing these biomarkers in routine clinical practice.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

Area of Science:

  • Implementation Science
  • Biomarker Development
  • Neurology

Background:

  • High-accuracy blood-based biomarkers (BBMs) offer a potential solution for accessible and scalable confirmation of amyloid pathology in Alzheimer's disease (AD).
  • Current diagnostic pathways for AD can be invasive and costly, highlighting the need for simpler confirmation methods.

Purpose of the Study:

  • To investigate the feasibility of implementing BBMs as confirmatory diagnostic tools for AD in routine patient care.
  • To assess healthcare provider and system acceptability and appropriateness of using BBMs.
  • To explore perceived barriers and facilitators to BBM implementation using the Consolidated Framework for Implementation Research (CFIR).

Main Methods:

  • A multi-site, prospective implementation science study employing mixed methods.
  • Data collection through electronic surveys (up to 20 participants) and semi-structured interviews (11 participants) and focus groups (up to 20 participants).
  • Utilizing the CFIR framework to systematically analyze implementation factors.

Main Results:

  • Quantitative data on feasibility, acceptability, and appropriateness of BBMs will be reported from surveys.
  • Qualitative data from interviews will identify perceived barriers and facilitators to BBM implementation.
  • Analysis will include participant characteristics and constructs predicting clinical practice changes.

Conclusions:

  • Findings will illuminate the feasibility and potential challenges of integrating confirmatory BBMs into standard AD care.
  • Real-world evaluation of BBMs can streamline the AD patient care pathway.
  • Successful implementation offers clinicians a minimally invasive, non-ionizing diagnostic tool for AD.